Lu, Xue-chun <br/><br/>
Clinical study of autologous cytokine-induced killer cells for the treatment of elderly patients with diffuse large B-cell lymphoma.  [electronic resource] 

 -  Cell biochemistry and biophysics  Jan 2012 
 - 257-65 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1559-0283 
<br/><br/><label>Standard No.: </label>10.1007/s12013-011-9273-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal--immunology<br/>CD3 Complex--immunology<br/>CD56 Antigen--metabolism<br/>CD8 Antigens--metabolism<br/>Cells, Cultured<br/>Cytokine-Induced Killer Cells--immunology<br/>Female<br/>Humans<br/>Immunotherapy<br/>Interferon-gamma--pharmacology<br/>Interleukin-2--pharmacology<br/>L-Lactate Dehydrogenase--blood<br/>Lymphoma, Large B-Cell, Diffuse--diagnostic imaging<br/>Macroglobulins--analysis<br/>Male<br/>Middle Aged<br/>Multimodal Imaging<br/>Positron-Emission Tomography<br/>Survival Analysis<br/>Tomography, X-Ray Computed<br/>Transplantation, Autologous<br/>Treatment Outcome